Scoping Review on Use of Drugs Targeting Interleukin 1 Pathway in DIRA and DITRA
Abstract Introduction Deficiencies in interleukin (IL)-1 receptor (IL-R) antagonist (DIRA) and IL-36R antagonist (DITRA) are rare genetic autoinflammatory diseases related to alterations in antagonists of the IL-1 pathway. IL-1 antagonists may represent therapeutic alternatives. Here, we aim to prov...
Main Authors: | Francisco Gómez-García, Juan L. Sanz-Cabanillas, Isabel Viguera-Guerra, Beatriz Isla-Tejera, Antonio Vélez-García Nieto, Juan Ruano |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2018-11-01
|
Series: | Dermatology and Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1007/s13555-018-0269-7 |
Similar Items
-
Woronoff Ring in Deficiency of Interleukin-36 Receptor Antagonist (DITRA)
by: Daniel Morgado-Carasco, et al.
Published: (2019-12-01) -
A case report of a novel compound heterozygous mutation in a Brazilian patient with deficiency of Interleukin-1 receptor antagonist (DIRA)
by: Leonardo Oliveira Mendonça, et al.
Published: (2020-08-01) -
Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents
by: Toni Hospach, et al.
Published: (2019-07-01) -
Deficiency of interleukin-1 receptor antagonist: An updated review of the pathogenesis, clinical characteristics, and treatments
by: Spencer Fang, et al.
Published: (2024-12-01) -
A snapshot on the on-label and off-label use of the interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: a nationwide multi-center retrospective observational study
by: Antonio Vitale, et al.
Published: (2016-10-01)